For example, an early preclinical study used an adenoviral vector expressing epitopes from the latent proteins LMP1 and LMP2 that successfully reduced tumor burden and increased survival in mice bearing LMP1-expressing tumors [74]. The gene discussed is PSMB9; the disease is neoplasm.